ESSA PHARMA INC (EPIX) Stock Income Statement
USA - NASDAQ:EPIX - CA29668H7085 - Common Stock
0.1934 USD
-0.01 (-3.78%)
0.1954 USD
+0 (+1.03%)
| TTM (2025-6-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 62.80K | 99.20K | 62.80K | 80.00K | 70.00K | |||
| Gross Profit | -62.80K | -99.20K | -62.80K | -80.00K | -70.00K | |||
| Operating Expenses | 29.60M | 34.32M | 32.08M | 36.89M | 37.09M | |||
| Research and Development | 12.55M | 21.11M | 21.26M | 24.33M | 24.19M | |||
| Selling, General, and Administrative Expenses | 17.04M | 13.21M | 11.37M | 12.56M | 12.89M | |||
| Operating Income | -29.66M | -34.42M | -32.14M | -36.97M | -37.16M | |||
| Interest Income/Expense | 4.54M | 5.88M | 5.56M | 1.76M | 320.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -25.12M | -28.54M | -26.58M | -35.22M | -36.84M | |||
| Income Tax | N/A | 0.00 | 1.60K | -110.00K | -30.00K | |||
| Net Income | -25.12M | -28.54M | -26.58M | -35.10M | -36.81M | |||
| EBITDA | -29.57M | -34.33M | -32.02M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.57 | -0.64 | -0.60 | -0.80 | -0.96 | |||
| Non GAAP EPS | N/A | -0.64 | -0.60 | -0.80 | -0.97 | |||
| Statistics | ||||||||
All data in USD